Israel - engelsk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - montelukast as sodium salt - tablets - montelukast as sodium salt 10 mg - montelukast - montelukast - montelukast - trima is indicated in adult and pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. montelukast - trima is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast - trima and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast - trima is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.

Israel - engelsk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - voriconazole - tablets - voriconazole 200 mg - voriconazole - treatment of: invasive aspergillosis, candidemia in non-neutropenic patients, fluconazole-resistant serious invasive candida infections (including c. krusei), serious fungal infections caused by scedosporium spp. and fusarium spp. voriconazole should be administered primarily to immunocompromised patients with progressive, possibly life-threatening infections. prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (hsct) recipients.

Israel - engelsk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - cinacalcet as hydrochloride - film coated tablets - cinacalcet as hydrochloride 30 mg - cinacalcet - treatment of secondary hyperparathyroidism (hpt) in patients with end-stage renal disease (esrd) on maintenance dialysis therapy. cinacalcet -trima may be used as part of a therapeutic regimen including phosphate binders and/or vitamin d sterols, as appropriate. reduction of hypercalcaemia in patients with:• parathyroid carcinoma.• primary hpt for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated.

Israel - engelsk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - cinacalcet as hydrochloride - film coated tablets - cinacalcet as hydrochloride 60 mg - cinacalcet - treatment of secondary hyperparathyroidism (hpt) in patients with end-stage renal disease (esrd) on maintenance dialysis therapy. cinacalcet -trima may be used as part of a therapeutic regimen including phosphate binders and/or vitamin d sterols, as appropriate. reduction of hypercalcaemia in patients with:• parathyroid carcinoma.• primary hpt for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated.

Israel - engelsk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - cinacalcet as hydrochloride - film coated tablets - cinacalcet as hydrochloride 90 mg - cinacalcet - treatment of secondary hyperparathyroidism (hpt) in patients with end-stage renal disease (esrd) on maintenance dialysis therapy. cinacalcet -trima may be used as part of a therapeutic regimen including phosphate binders and/or vitamin d sterols, as appropriate. reduction of hypercalcaemia in patients with:• parathyroid carcinoma.• primary hpt for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated.

Israel - engelsk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - rasagiline as mesylate - tablets - rasagiline as mesylate 1 mg - rasagiline - treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.

Israel - engelsk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - solifenacin succinate - tablets - solifenacin succinate 10 mg - solifenacin - for symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome

Israel - engelsk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - solifenacin succinate - tablets - solifenacin succinate 5 mg - solifenacin - for symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome

Israel - engelsk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fexofenadine hydrochloride - film coated tablets - fexofenadine hydrochloride 120 mg - fexofenadine - relief of symptoms associated with seasonal allergic rhinitis.

Israel - engelsk - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fexofenadine hydrochloride - film coated tablets - fexofenadine hydrochloride 180 mg - fexofenadine - relief of symptoms associated with chronic idiopathic urticaria